Infection and Chemotherapy最新文献

筛选
英文 中文
Korea's National Action Plan on Antimicrobial Resistance: Focusing on the Appropriate Use of Antibiotics. 韩国抗菌素耐药性国家行动计划:重点是抗生素的适当使用。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-05-22 DOI: 10.3947/ic.2025.0028
Young-Il Jeong, Hwa-Young Lee, Shinyoung Lee, Ga Yeong Jeong, Seo Hyun Kim, Seungyun Kim, Seung-Hee Seo, Na-Ri Shin
{"title":"Korea's National Action Plan on Antimicrobial Resistance: Focusing on the Appropriate Use of Antibiotics.","authors":"Young-Il Jeong, Hwa-Young Lee, Shinyoung Lee, Ga Yeong Jeong, Seo Hyun Kim, Seungyun Kim, Seung-Hee Seo, Na-Ri Shin","doi":"10.3947/ic.2025.0028","DOIUrl":"https://doi.org/10.3947/ic.2025.0028","url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) is recognized as one of the top ten global public health threats. Since the coronavirus disease 2019 pandemic, there has been a notable increase in global concern regarding AMR, leading to a strong call for a government-led response to address this issue. Since 2016, the Korean government has established and implemented a robust social foundation for managing AMR. This foundation encompasses several elements: enhancing the medical environment for infection prevention, providing support for the antimicrobial stewardship program in healthcare organizations, strengthening cooperation among multidisciplinary policy ministries, requiring veterinarians to prescribe antimicrobials in non-human fields, and enhancing food safety management in livestock and aquatic products. However, as the threat of AMR has intensified during the ongoing pandemic, the necessity for implementing a National Action Plan becomes even more critical. Therefore, the Third National Action Plan 2026-2030 is crucial to take into account several critical factors: raising awareness of AMR, strengthening of antimicrobial stewardship, halting the spread of antimicrobial-resistant bacteria, strengthening surveillance of antimicrobial use and AMR rates, strengthening internal and external collaborative efforts to combat AMR, and the final factor to consider is to enhance further antimicrobial development and diagnostic technologies to better manage and prevent AMR.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing COVID-19 in Correctional Facilities: The Impact of Rapid Antigen Tests on Early Detection and Infection Control. 在教养所预防COVID-19:快速抗原检测对早期发现和感染控制的影响
IF 2.8
Infection and Chemotherapy Pub Date : 2025-05-22 DOI: 10.3947/ic.2024.0080
Hye Young Lee, Young-Joon Park, Sang-Eun Lee, Ji Joo Lee, Jihyun Choi, Mi Yu, Hanul Park, Hee Seok Park, Jun Yeop Kim, Jun Young Moon
{"title":"Preventing COVID-19 in Correctional Facilities: The Impact of Rapid Antigen Tests on Early Detection and Infection Control.","authors":"Hye Young Lee, Young-Joon Park, Sang-Eun Lee, Ji Joo Lee, Jihyun Choi, Mi Yu, Hanul Park, Hee Seok Park, Jun Yeop Kim, Jun Young Moon","doi":"10.3947/ic.2024.0080","DOIUrl":"https://doi.org/10.3947/ic.2024.0080","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management. 后covid -19时代百日咳的应对:死灰复燃、诊断和管理。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-05-07 DOI: 10.3947/ic.2025.0010
Sudip Bhattacharya
{"title":"Response to Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management.","authors":"Sudip Bhattacharya","doi":"10.3947/ic.2025.0010","DOIUrl":"https://doi.org/10.3947/ic.2025.0010","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Response to Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management. 回复:应对后covid -19时代百日咳:死灰复燃,诊断和管理。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-05-07 DOI: 10.3947/ic.2025.0014
Hyun Mi Kang, Taek-Jin Lee, Su Eun Park, Soo-Han Choi
{"title":"Reply: Response to Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management.","authors":"Hyun Mi Kang, Taek-Jin Lee, Su Eun Park, Soo-Han Choi","doi":"10.3947/ic.2025.0014","DOIUrl":"https://doi.org/10.3947/ic.2025.0014","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options. 回复:对韩国儿童RSV预防策略的回应:当前方法和新选择的回顾。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-05-02 DOI: 10.3947/ic.2025.0039
Young June Choe
{"title":"Reply: Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options.","authors":"Young June Choe","doi":"10.3947/ic.2025.0039","DOIUrl":"https://doi.org/10.3947/ic.2025.0039","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options. 对韩国儿童RSV预防策略的回应:当前方法和新选择的回顾。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-05-02 DOI: 10.3947/ic.2025.0024
Sudip Bhattacharya
{"title":"Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options.","authors":"Sudip Bhattacharya","doi":"10.3947/ic.2025.0024","DOIUrl":"https://doi.org/10.3947/ic.2025.0024","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations for Influenza Vaccination in Immunocompromised Patients. 免疫功能低下患者接种流感疫苗的建议。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-04-30 DOI: 10.3947/ic.2025.0033
Joon Young Song, Ki Tae Kwon, Wan Beom Park, Ji Yun Noh, Sun Hee Park, Eun Ju Choo, Min Joo Choi, Jun Yong Choi, Jung Yeon Heo, Won Suk Choi
{"title":"Recommendations for Influenza Vaccination in Immunocompromised Patients.","authors":"Joon Young Song, Ki Tae Kwon, Wan Beom Park, Ji Yun Noh, Sun Hee Park, Eun Ju Choo, Min Joo Choi, Jun Yong Choi, Jung Yeon Heo, Won Suk Choi","doi":"10.3947/ic.2025.0033","DOIUrl":"https://doi.org/10.3947/ic.2025.0033","url":null,"abstract":"<p><p>Annual influenza vaccination is strongly recommended for immunocompromised individuals, who are at a higher risk of severe infection. The Korean Society of Infectious Diseases has revised its influenza vaccination recommendations for solid organ transplant recipients, advocating for the use of highly immunogenic vaccines, such as high-dose inactivated influenza vaccines or MF59-adjuvanted inactivated influenza vaccines, to enhance vaccine efficacy. While further research is needed to extend these recommendations to other immunocompromised populations, these vaccines have demonstrated improved immunogenicity without compromising safety. Expanding vaccination guidelines to additional immunocompromised groups should be considered as more evidence emerges.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial Prescribing Patterns in Russian Outpatients in 2024: Results of the Global-PPS Project. 2024年俄罗斯门诊患者抗菌药物处方模式:全球pps项目结果
IF 2.8
Infection and Chemotherapy Pub Date : 2025-04-29 DOI: 10.3947/ic.2024.0144
Svetlana Rachina, Yuliya Belkova, Roman Kozlov, Anastasia Kurkova, Annelies Boven, Ann Versporten, Ines Pauwels, Erika Vlieghe, Aleksandr Stafeev, Sergey Zyryanov, Veriko Kukava, Elena Bochanova, Ekaterina Eliseeva, Galina Ketova, Elena Luchsheva, Shamil Palyutin, Irina Panshina, Ulyana Portnyagina, Olga Reshetko, Vera Shegimova, Mikhail Shutov, Natalya Titova, Sergey Yakushin
{"title":"Antimicrobial Prescribing Patterns in Russian Outpatients in 2024: Results of the Global-PPS Project.","authors":"Svetlana Rachina, Yuliya Belkova, Roman Kozlov, Anastasia Kurkova, Annelies Boven, Ann Versporten, Ines Pauwels, Erika Vlieghe, Aleksandr Stafeev, Sergey Zyryanov, Veriko Kukava, Elena Bochanova, Ekaterina Eliseeva, Galina Ketova, Elena Luchsheva, Shamil Palyutin, Irina Panshina, Ulyana Portnyagina, Olga Reshetko, Vera Shegimova, Mikhail Shutov, Natalya Titova, Sergey Yakushin","doi":"10.3947/ic.2024.0144","DOIUrl":"https://doi.org/10.3947/ic.2024.0144","url":null,"abstract":"<p><strong>Background: </strong>Detailed surveillance of antimicrobials' use in the community is an essential strategy to control their overuse and misuse. This study aimed to evaluate prescribing patterns of antimicrobials in Russian outpatients in 2024 and quantify the prescribing in relation to quality indicators.</p><p><strong>Materials and methods: </strong>A point prevalence study was conducted during January-April 2024 in 14 healthcare facilities in 11 Russian cities (Chelyabinsk, Ekaterinburg, Krasnoyarsk, Moscow, Novokuznetsk, Saratov, Smolensk, Ulan-Ude, Vladivostok, Yakutsk, and Yaroslavl) in accordance with the outpatient protocol of Global-PPS project. Detailed data on antimicrobials, age, gender, and drug indications were collected for each outpatient receiving at least one agent for prophylaxis or treatment.</p><p><strong>Results: </strong>A total of 5,084 outpatients from 149 units were surveyed, of which 487 (9.6%) received at least one antimicrobial agent. The highest rates of antimicrobial prescribing were observed at upper respiratory tract (33.2%), gastroenterology (22.6%), hematology (13.6%), ear nose and throat (13.5%), and gynecology units (11.6%). Antibacterials accounted for 63.4% of antimicrobials on average, followed by antivirals (35.4%). Penicillins (41.4%), for the most part penicillin/beta-lactamase inhibitor combinations (30.1%), cephalosporins (18.3%), including third generation (17.7%), fluoroquinolones (16.1%), and macrolides (11.5%) were the top classes of antibiotics prescribed. Umifenovir (23.8%) and amoxicillin/clavulanic acid (19.0%) were the top antimicrobials prescribed. The administered antibacterials were almost equally distributed between \"access\" (46.5%) and \"watch\" (53.5%) AWaRe groups. On average, choice of antimicrobials followed the national guidelines issued by the Ministry of Health in 73.2% of cases.</p><p><strong>Conclusion: </strong>The pooled rates of antimicrobial prescribing in outpatient settings was 9.6% with the substantial differences in patterns of consumption overall and among the units of different types. Broad-spectrum antibacterials such as penicillin/beta-lactamase inhibitor combinations, III-IV generation cephalosporins, fluoroquinolones, and macrolides together amounted to 48% of prescriptions. Common concerns in antimicrobial drug usage included low guidelines compliance and low rate of \"access\" group antibacterials.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening Antimicrobial Stewardship in Korea: Strategies to Address Workforce Gaps and Expand ASP Nationwide. 加强韩国的抗菌药物管理:解决劳动力缺口和在全国推广抗菌药物管理的战略。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-04-28 DOI: 10.3947/ic.2024.0135
Tark Kim, Rebekah W Moehring, Elizabeth Dodds Ashley, Hyung-Sook Kim, Deverick J Anderson
{"title":"Strengthening Antimicrobial Stewardship in Korea: Strategies to Address Workforce Gaps and Expand ASP Nationwide.","authors":"Tark Kim, Rebekah W Moehring, Elizabeth Dodds Ashley, Hyung-Sook Kim, Deverick J Anderson","doi":"10.3947/ic.2024.0135","DOIUrl":"https://doi.org/10.3947/ic.2024.0135","url":null,"abstract":"<p><p>Given the global threat of antimicrobial-resistant organisms, an effective antimicrobial stewardship program (ASP) is essential. Infectious disease (ID) physicians and ID-trained pharmacists are prioritized as critical core members of ASP in hospital settings, but securing these ID-trained professionals in all settings is challenging. Alternative champions and personnel for implementation may be needed. This narrative review highlights the efficacy of ASP when non-ID-trained physicians and pharmacists are engaged in ASP, showcasing various studies demonstrating significant improvements in antimicrobial utilization, cost, and patient outcomes. Additionally, it discusses the impact of network-based models, such as the Duke Antimicrobial Stewardship Outreach Network, which provides structured support and resources to lower-resourced hospitals to ensure the successful implementation of ASP. Ultimately, this narrative review provides insights into how to structure accountability and pharmacy/stewardship expertise in establishing and expanding ASP nationwide in Korea, where ASP is still in its early stages. In addressing this issue, government initiatives to actively support this effort are essential, and striving to develop evidence-based policies is necessary.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human Metapneumovirus: A Comprehensive Epidemiological Analysis of a Global Respiratory Threat. 人偏肺病毒:全球呼吸道威胁的综合流行病学分析。
IF 2.8
Infection and Chemotherapy Pub Date : 2025-04-17 DOI: 10.3947/ic.2025.0019
Sudip Bhattacharya, Samiksha Bhattacharjee, Alok Singh
{"title":"Human Metapneumovirus: A Comprehensive Epidemiological Analysis of a Global Respiratory Threat.","authors":"Sudip Bhattacharya, Samiksha Bhattacharjee, Alok Singh","doi":"10.3947/ic.2025.0019","DOIUrl":"https://doi.org/10.3947/ic.2025.0019","url":null,"abstract":"<p><p>Human metapneumovirus (HMPV) is a significant respiratory pathogen that contributes to acute respiratory infections, particularly in vulnerable populations such as children, the elderly, and immunocompromised individuals. Since its discovery in 2001, HMPV has become a global health concern, with epidemiological data revealing seasonal peaks and notable genetic diversity. The virus is associated with a wide range of respiratory illnesses, including bronchiolitis, pneumonia, and asthma exacerbations, leading to substantial hospitalization rates and healthcare costs. This review examines the epidemiology of HMPV, focusing on pre- and post-coronavirus disease 2019 (COVID-19) trends, transmission patterns, and the impact on at-risk populations. Notably, the COVID-19 pandemic has influenced the seasonality of HMPV, with altered patterns of viral circulation and co-infection with other respiratory pathogens, such as respiratory syncytial virus and influenza. Despite its considerable impact, HMPV remains under-recognized and lacks specific antivirals or vaccines, leaving management largely supportive. Advances in molecular diagnostics, including RT-PCR and potential serological methods, offer hope for improved detection and epidemiological tracking. Moreover, research into monoclonal antibodies, antiviral treatments, and vaccines is ongoing, with promising results in preclinical models. Enhanced surveillance systems and integrated approaches to monitor co-circulating viruses are essential for mitigating the burden of HMPV. This review underscores the need for continued research, public health strategies, and global collaboration to address the challenges posed by HMPV, particularly in high-risk populations and regions with limited healthcare infrastructure.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144017587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信